Actual Medicinal Product (AMP) Palexia 50mg tablets (Grunenthal Ltd)

Stability Information

(Some stability information inherited from generic)

Stability
compatible logo Suitable for use in MCAs, although use is likely to be off-label. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
Notes

No special storage conditions required.

Provenance

This compatibility recommendation is derived from Palexia 50mg tablets (Grunenthal Ltd).

Generic
Tapentadol
Formulation
Tapentadol 50mg tablets
  • Tapentadol
    • Tapentadol 50mg tablets

      • Palexia 50mg tablets (Grunenthal Ltd)